Hie inhibitory function of CD4CD25+T regulatory cells is impaired in relapsing-remitting multiple sclerosis but not in primary progressive multiple sclerosis

被引：0
|
作者：
Putzki, Norman [1 ]
Kamou, Roulat [1 ]
Kumar, Manoj [1 ]
Kreuzfelder, Ernst [1 ]
机构：
[1] Univ Clin Essen, Dept Neurol, Essen, Germany
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [1] T Regulatory Cell Function Is Impaired in Relapsing Remitting but Not in Primary Progressive Multiple Sclerosis
    Yaldizli, Oezguer
    Kamou, Roulat
    Putzki, Norman
    NEUROLOGY, 2009, 72 (11) : A37 - A37
  • [2] CD127-depleted CD4+ CD25high regulatory T cells display a normal function in relapsing-remitting multiple sclerosis patients
    Michel, Laure
    Berthelot, Laureline
    Pettre, Segolene
    Wiertlewski, Sandrine
    Le Frere, Fabienne
    Braudeau, Cecile
    Brouard, Sophie
    Soulillou, Jean Paul
    Laplaud, David
    CLINICAL IMMUNOLOGY, 2008, 127 : S15 - S15
  • [3] Prodrome in relapsing-remitting and primary progressive multiple sclerosis
    Wijnands, J. M. A.
    Zhu, F.
    Kingwell, E.
    Zhao, Y.
    Evans, C.
    Fisk, J. D.
    Marrie, R. A.
    Tremlett, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (07) : 1032 - 1036
  • [4] Redox Imbalance in CD4+T Cells of Relapsing-Remitting Multiple Sclerosis Patients
    Tavassolifar, Mohammad Javad
    Moghadasi, Abdorreza Naser
    Esmaeili, Behnaz
    Sadatpour, Omid
    Vodjgani, Mohammad
    Izad, Maryam
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [5] Impaired function of CD4+CD25high regulatory T cells in patients with multiple sclerosis
    Haas, J
    Vetter, T
    Milkova, L
    Viehöver, A
    Hug, A
    Falk, C
    Suri-Payer, E
    Fritz, B
    Krammer, P
    Wildemann, B
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 225 - 225
  • [6] Loss of inhibitory function of CD4+CD25+ regulatory T cells in multiple sclerosis patients
    Putzki, N
    Kumar, M
    Vago, S
    Kreutzfelder, E
    Limmroth, V
    NEUROLOGY, 2006, 66 (05) : A373 - A373
  • [7] Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study
    Chwojnicki, Kamil
    Iwaszkiewicz-Grzes, Dorota
    Jankowska, Anna
    Zielinski, Maciej
    Lowiec, Pawel
    Gliwinski, Mateusz
    Grzywinska, Malgorzata
    Kowalczyk, Kamil
    Konarzewska, Aleksandra
    Glasner, Paulina
    Sakowska, Justyna
    Kulczycka, Julia
    Jazwinska-Curyllo, Anna
    Kubach, Marlena
    Karaszewski, Bartosz
    Nyka, Walenty
    Szurowska, Edyta
    Trzonkowski, Piotr
    BIODRUGS, 2021, 35 (01) : 47 - 60
  • [8] CD4+CD25+FoxP3+PD1 - regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy
    Saresella, Marina
    Marventano, Ivana
    Longhi, Renato
    Lissoni, Francesca
    Trabattoni, Daria
    Mendozzi, Laura
    Caputo, Domenico
    Clerici, Mario
    FASEB JOURNAL, 2008, 22 (10): : 3500 - 3508
  • [9] Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis
    Xu, L.
    Xu, Z.
    Xu, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 158 (01): : 26 - 30
  • [10] Action of CD4+CD25+ regulatory T cells is impaired in multiple sclerosis patients
    Putzki, N
    Kumar, M
    Vago, S
    Kreuzfelder, E
    Limmroth, V
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S243 - S243
12345